Sign Up Today and Learn More About Life Biosciences Stock
Invest in or calculate the value of your shares in Life Biosciences or other pre-IPO companies through EquityZen's platform.
Life Biosciences Stock
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
About Life Biosciences Stock
Founded
2017
Headquarters
Boston, MA, US
Industries
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases. Developer of drugs designed to promote longevity and find treatments for age-related diseases. The company's drugs help to combat the eight pathways of age-related decline and it's work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases with a view to ultimately extending healthy life spans.
Life Biosciences Press Mentions
Stay in the know about the latest news on Life Biosciences
Forge fires up gene therapy production partnership with Life Biosciences
fiercepharma • May 09, 2023
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates
globenewswire • Apr 23, 2023
Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Round
prnewswire • Jan 05, 2022
Startup aims to treat Alzheimer's by invigorating neurons' garbage-disposal abilities
fiercebiotech • Apr 23, 2021
WeWork founder sounds bonkers, but he sure does love marijuana
chicagotribune • Sep 23, 2019
Life Biosciences Management
Leadership team at Life Biosciences
Chief Executive Officer
Mehmood Khan
CIO
Tristan Edwards
Join now and verify your accreditation status to gain access to:
- Life Biosciences current valuation
- Life Biosciences stock price
- Available deals in Life Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Life Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Life Biosciences through EquityZen funds. These investments are made available by existing Life Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Life Biosciences stock?
Shareholders can sell their Life Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
